Apcegen is fully integrated Innovation driven biopharmaceutical company, with
headquarter in Bangalore, INDIA and development centre at SIDBI Innovation and
Incubation Centre, Indian Institute of Technology IIT Kanpur, INDIA.
Apcegen aims to develop, manufacture and commercialize affordable biopharmaceuticals
for the treatment of inflammation and other life threatening medical conditions.
The research group at Apcegen focuses on pathway engineering, development of
proprietary expression platforms for Microbial and Mammalian systems, and development
of novel and scalable processes in microbial and mammalian systems.
Apcegen Technologies will use its skills to make affordable biotechnology based
healthcare solutions through cGMP compliant fast track development of bioprocesses for
the development of cutting edge biotherapeutic products. The unique expertise available
with Apcegen Technologies for developing cost effective and efficient bioprocesses will
enable rapid and efficient commercialization of affordable, high quality recombinant
Name and contact details of Chairperson/Managing director
Development of novel, cost effective and safer alternate biologics.
Development of next generation biotech based drugs.
Development of Nano-bio platforms
Ashutosh Vyas, CEO
D105, SIIC Extension
IIT Kanpur, Kanpur - 208016
We are committed to the welfare of the society through bio-innovation. The present project is the first step in our endeavor wherein we have aimed to provide a better and cost effective solution to the people suffering from TNF related autoimmune disorder